Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvation Bio, Inc.

2.27
+0.02000.89%
Post-market: 2.270.00000.00%16:20 EDT
Volume:2.15M
Turnover:4.84M
Market Cap:771.05M
PE:-1.07
High:2.29
Open:2.25
Low:2.20
Close:2.25
Loading ...

Company Profile

Company Name:
Nuvation Bio, Inc.
Exchange:
NYSE
Establishment Date:
2018
Employees:
220
Office Location:
1500 Broadway,Suite 1401,New York,New York,United States
Website:
- -
Zip Code:
10036
Fax:
- -
Introduction:
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung , M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco .

Directors

Name
Position
Sarah Marriott
Secretary and Director

Shareholders

Name
Position
Oleg Nodelman
Chief Executive Officer
Scott Platshon
Chief Operating Officer
Scott Perlen
Chief Financial Officer
Caroline Stout
Chief Investment Officer
Sarah Marriott
Secretary and Director